Human papilloma virus (HPV) in lung cancer: Unanswered questions

Lung Cancer

Volumn 67, Issue 1, 2010, Pages 125-

  Kountouri, Melpomeni P ^a   Mammas, Ioannis N ^b   Spandidos, Demetrios A ^b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN E6; PROTEIN P53; RETINOBLASTOMA PROTEIN;

CANCER RISK; CAUSAL ATTRIBUTION; HUMAN; INCIDENCE; LETTER; LUNG CANCER; LUNG CARCINOGENESIS; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; VIRUS CARCINOGENESIS; VIRUS ENTRY; VIRUS TRANSMISSION; WART VIRUS;

ALPHAPAPILLOMAVIRUS; HUMANS; INCIDENCE; LUNG NEOPLASMS; PAPILLOMAVIRUS INFECTIONS;

EID: 71549143765     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.10.020     Document Type: Letter

References (9)

1. Klein F., Amin Kotb W.F., and Petersen I. Incidence of human papilloma virus in lung cancer. Lung Cancer 65 (2009) 13-18
2. Stanley M.A., Pett M.R., and Coleman N. HPV: from infection to cancer. Biochem Soc Trans 35 (2007) 1456-1460
3. Tseng C.J., Pao C.C., Lin J.D., Soong Y.K., Hong J.H., and Hsueh S. Detection of human papillomavirus types 16 and 18 mRNA in peripheral blood of advanced cervical cancer patients and its association with prognosis. J Clin Oncol 17 (1999) 1391-1396
4. Chen Y.C., Chen J.H., Richard K., Chen P.Y., and Christiani D.C. Lung adenocarcinoma and human papillomavirus infection. Cancer 101 (2004) 1428-1436
5. Selinka H.C., Florin L., Patel H.D., Freitag K., Schmidtke M., Makarov V.A., et al. Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus. J Virol 81 (2007) 10970-10980
6. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., and Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63 (1990) 1129-1136
7. Cheng Y.W., Chiou H.L., Chen J.T., Chou M.C., Lin T.S., Lai W.W., et al. Gender difference in human papillomarvirus infection for non-small cell lung cancer in Taiwan. Lung Cancer 46 (2004) 165-170
8. Weichert W., Schewe C., Denkert C., Morawietz L., Dietel M., and Petersen I. Molecular HPV typing as a diagnostic tool to discriminate primary from metastatic squamous cell carcinoma of the lung. Am J Surg Pathol 33 (2009) 513-520
9. Hsu N.Y., Cheng Y.W., Chan I.P., Ho H.C., Chen C.Y., Hsu C.P., et al. Association between expression of human papillomavirus 16/18 E6 oncoprotein and survival in patients with stage I non-small cell lung cancer. Oncol Rep 21 (2009) 81-87